85 related articles for article (PubMed ID: 22116592)
1. Identification of two de novo mutations responsible for type I antithrombin deficiency.
Orlando C; Lissens W; Hasaerts D; Jochmans K
Thromb Haemost; 2012 Jan; 107(1):187-9. PubMed ID: 22116592
[No Abstract] [Full Text] [Related]
2. [Molecular mechanisms of recurrent venous thrombosis in two pedigrees with type I antithrombin deficiency].
Xia Y; Ding QL; Xu GQ; Zhang LW; Dai J; Lu YL; Wang XF; Xi XD; Wang HL
Zhonghua Xue Ye Xue Za Zhi; 2011 Dec; 32(12):848-53. PubMed ID: 22339960
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms of antithrombin deficiency in two Chinese families. One novel and one recurrent point mutation in the antithrombin gene causing venous thrombosis.
Zhou RF; Fu QH; Wang WB; Xie S; Dai J; Ding QL; Wang XF; Wang HL; Wang ZY
Thromb Haemost; 2005 Dec; 94(6):1172-6. PubMed ID: 16411389
[TBL] [Abstract][Full Text] [Related]
4. Life-threatening thrombosis in mice with targeted Arg48-to-Cys mutation of the heparin-binding domain of antithrombin.
Dewerchin M; Hérault JP; Wallays G; Petitou M; Schaeffer P; Millet L; Weitz JI; Moons L; Collen D; Carmeliet P; Herbert JM
Circ Res; 2003 Nov; 93(11):1120-6. PubMed ID: 14592998
[TBL] [Abstract][Full Text] [Related]
5. [Type I hereditary antithrombin deficiency due to C2757T heterozygotic mutation in antithrombin gene].
Zhou RF; Dai Q; Fu QH; Wang WB; Xue S; Ding QL; Hu YQ; Wang XF; Wang HL
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(23):1640-2. PubMed ID: 16185535
[No Abstract] [Full Text] [Related]
6. Arterial and venous thrombosis and prothrombotic fibrin clot phenotype in a Polish family with type 1 antithrombin deficiency (antithrombin Krakow).
Celinska-Lowenhoff M; Iwaniec T; Alhenc-Gelas M; Musial J; Undas A
Thromb Haemost; 2011 Aug; 106(2):379-81. PubMed ID: 21655678
[No Abstract] [Full Text] [Related]
7. [Molecular basis of hereditary antithrombin defects in 10 Czech families].
Hrachovinová I; Habart D; Salaj P; Matysková M; Vorlová Z
Cas Lek Cesk; 2000 Sep; 139(19):596-8. PubMed ID: 11192751
[TBL] [Abstract][Full Text] [Related]
8. Homozygous factor V Leiden mutation and disseminated thrombosis in a patient with nephrotic syndrome.
Kahveci A; Seyahi N; Seyahi E; Altiparmak MR; Ataman R; Serdengecti K
J Nephrol; 2007; 20(1):103-6. PubMed ID: 17347983
[TBL] [Abstract][Full Text] [Related]
9. Coexistence of three genetic risk factors in a Spanish thrombophilic family: Factor V Leiden, prothrombin 20210 and a new type I antithrombin deficiency.
Ordóñez A; de Cos C; Miñano A; Rodríguez J; Hernández-Espinosa D; Muñoz JA; González-Conejero R; Vicente V; Corral J
Thromb Haemost; 2007 Jan; 97(1):153-5. PubMed ID: 17200784
[No Abstract] [Full Text] [Related]
10. Cerebral venous thrombosis during pregnancy in the setting of type I antithrombin deficiency: case report and literature review.
Sharpe CJ; Crowther MA; Webert KE; Donnery C
Transfus Med Rev; 2011 Jan; 25(1):61-5. PubMed ID: 21134627
[TBL] [Abstract][Full Text] [Related]
11. Genetic analysis of mutations in seven Japanese families with type I antithrombin deficiency.
Ozawa T; Sakuragawa N
Semin Thromb Hemost; 1998; 24(3):233-6. PubMed ID: 9701453
[TBL] [Abstract][Full Text] [Related]
12. Combination of congenital coagulation disorders: Factor II gene mutation G20210A, Factor V Leiden gene mutation G1691A and protein S deficiency. a family study.
González CM; Díaz-Golpe V; Martín S; Sánchez Del Real J; Redondo MC
Haematologica; 2003 Jun; 88(6):ECR20. PubMed ID: 12801853
[No Abstract] [Full Text] [Related]
13. Molecular bases of antithrombin deficiency in French families: identification of seven novel mutations in the antithrombin gene.
Picard V; Bura A; Emmerich J; Alhenc-Gelas M; Biron C; Houbouyan-Reveillard LL; Molho P; Labatide-Alanore A; Sié P; Toulon P; Verdy E; Aiach M
Br J Haematol; 2000 Sep; 110(3):731-4. PubMed ID: 10997988
[TBL] [Abstract][Full Text] [Related]
14. Hereditary homozygous heparin cofactor II deficiency and the risk of developing venous thrombosis.
Villa P; Aznar J; Vaya A; España F; Ferrando F; Mira Y; Estellés A
Thromb Haemost; 1999 Sep; 82(3):1011-4. PubMed ID: 10494755
[TBL] [Abstract][Full Text] [Related]
15. [Type I antithrombin deficiency as a cause of arterial and venous thrombosis in a family with severe thrombophilia].
Tóth O; Dávid M; Habon T; Nagy A; Keszthelyi Z; Kovács N; Losonczy H
Orv Hetil; 2005 Oct; 146(41):2121-5. PubMed ID: 16304806
[TBL] [Abstract][Full Text] [Related]
16. Homozygous antithrombin deficiency: report of two new cases (99 Leu to Phe) associated with arterial and venous thrombosis.
Chowdhury V; Lane DA; Mille B; Auberger K; Gandenberger-Bachem S; Pabinger I; Olds RJ; Thein SL
Thromb Haemost; 1994 Aug; 72(2):198-202. PubMed ID: 7831651
[TBL] [Abstract][Full Text] [Related]
17. Inherited thrombophilia: an update.
Franchini M; Veneri D
Clin Lab; 2005; 51(7-8):357-65. PubMed ID: 16122145
[TBL] [Abstract][Full Text] [Related]
18. Antithrombin alfa in hereditary antithrombin deficient patients: A phase 3 study of prophylactic intravenous administration in high risk situations.
Tiede A; Tait RC; Shaffer DW; Baudo F; Boneu B; Dempfle CE; Horellou MH; Klamroth R; Lazarchick J; Mumford AD; Schulman S; Shiach C; Bonfiglio LJ; Frieling JT; Conard J; von Depka M
Thromb Haemost; 2008 Mar; 99(3):616-22. PubMed ID: 18327412
[TBL] [Abstract][Full Text] [Related]
19. Antithrombin Krakow II (c.624+1 G > T): a novel mutation leading to type 1 antithrombin deficiency.
Celinska-Löwenhoff M; Iwaniec T; Alhenc-Gelas M; Musial J; Undas A
Blood Coagul Fibrinolysis; 2012 Jul; 23(5):454-5. PubMed ID: 22498983
[TBL] [Abstract][Full Text] [Related]
20. Two novel mutations at contiguous codons in the fibrinogen Bbeta chain associated with hypofibrinogenaemia.
Davis RL; May S; Chunilal S; Brennan SO
Thromb Haemost; 2009 May; 101(5):980-2. PubMed ID: 19404555
[No Abstract] [Full Text] [Related]
[Next] [New Search]
